SRC and colonic neoplasm: Consistent with previous observations in human colon cancer cell lines and breast cancer cell lines 35-38, reducing SRC or inhibiting the FAK/PI3K axis blocked pressure-stimulated cell adhesion in liver cancer cell lines.